
Pharmaceutical Dosage Forms And Drug Delivery
by Mahato, Ram I.-
This Item Qualifies for Free Shipping!*
*Excludes marketplace orders.
Rent Textbook
New Textbook
We're Sorry
Sold Out
Used Textbook
We're Sorry
Sold Out
eTextbook
We're Sorry
Not Available
How Marketplace Works:
- This item is offered by an independent seller and not shipped from our warehouse
- Item details like edition and cover design may differ from our description; see seller's comments before ordering.
- Sellers much confirm and ship within two business days; otherwise, the order will be cancelled and refunded.
- Marketplace purchases cannot be returned to eCampus.com. Contact the seller directly for inquiries; if no response within two days, contact customer service.
- Additional shipping costs apply to Marketplace purchases. Review shipping costs at checkout.
Summary
Table of Contents
List of Illustrations | p. xix |
List of Tables | p. xxiii |
Foreword | p. xxv |
Preface | p. xxvii |
Acknowledgments | p. xxix |
About the Author | p. xxxi |
Drug Development and Regulatory Process | p. 1 |
Learning Objectives | p. 1 |
Introduction | p. 1 |
Identification of New Therapeutic Molecules | p. 2 |
Extraction from Plants | p. 2 |
Organic Synthesis | p. 3 |
Use of Animals | p. 4 |
Genetic Engineering | p. 4 |
Gene Therapy | p. 4 |
Preclinical Research | p. 4 |
Formulation Development | p. 5 |
Regulatory Issues | p. 5 |
Investigational New Drug (IND) Application | p. 5 |
Clinical Trials | p. 6 |
Phase I Clinical Trials | p. 6 |
Phase II Clinical Trials | p. 6 |
Phase III Clinical Trials | p. 7 |
New Drug Application (NDA) | p. 7 |
Approval and Postmarketing Surveillance | p. 7 |
Abbreviated New Drug Application (ANDA) | p. 8 |
Role of FDA's Advisory Committees | p. 8 |
Review Questions | p. 8 |
Bibliography | p. 9 |
Pharmaceutical and Formulation Considerations | p. 11 |
Learning Objectives | p. 11 |
Introduction | p. 11 |
Advantages of Pharmaceutical Dosage Forms | p. 11 |
Influential Factors in Dosage Form Design | p. 12 |
Molecular Size and Volume | p. 13 |
Drug Solubility and pH | p. 14 |
Lipophilicity and Partition Coefficient | p. 16 |
Polymorphism | p. 17 |
Stability | p. 19 |
pKa/Dissociation Constants | p. 20 |
Degree of Ionization and pH-Partition Theory | p. 24 |
Limitations of pH-Partition Theory | p. 24 |
Review Questions | p. 25 |
Bibliography | p. 26 |
Biopharmaceutical and Physiological Considerations | p. 29 |
Learning Objectives | p. 29 |
Introduction | p. 29 |
Drug Transport across a Polymeric Barrier | p. 30 |
Fick's Laws of Diffusion | p. 30 |
Fick's First Law of Diffusion | p. 30 |
Fick's Second Law of Diffusion | p. 32 |
Steady-State Conditions | p. 32 |
Lag Time | p. 34 |
Pore Diffusion | p. 34 |
Matrix (Monolithic)-Type Nondegradable Device | p. 35 |
Biological Membranes and Drug Absorption | p. 36 |
Passive Transport | p. 37 |
Simple Diffusion | p. 37 |
Carrier-Mediated Transport | p. 37 |
Channel-Mediated Transport | p. 37 |
Active Transport | p. 37 |
Fick's Law of Diffusion and Drug Absorption | p. 38 |
Dissolution Rate and Noyes-Whitney Equation of Dissolution | p. 40 |
Factors Influencing Dissolution Rate | p. 41 |
Physicochemical Properties | p. 41 |
Thickness of Diffusion Layer | p. 42 |
Gastrointestinal Fluids | p. 42 |
Particle Size | p. 42 |
Crystallinity | p. 42 |
Porosity and Tortuosity of Solid Particles | p. 43 |
Temperature | p. 43 |
Surfactants | p. 43 |
Drug Absorption and Bioavailability | p. 43 |
Review Questions | p. 43 |
Bibliography | p. 45 |
Complexation and Protein Binding | p. 47 |
Learning Objectives | p. 47 |
Introduction | p. 47 |
Types of Complexation | p. 47 |
Coordination Complexes | p. 48 |
Molecular Complexes | p. 48 |
Drug Complexes | p. 50 |
Polymer Complexes | p. 50 |
Inclusion Complexes | p. 50 |
Drug Interaction with Plasma Proteins | p. 52 |
Binding Equilibria | p. 52 |
Protein Binding | p. 54 |
Impact of Plasma Protein Binding on Dosing Regimens | p. 55 |
Review Questions | p. 56 |
Bibliography | p. 57 |
Chemical Kinetics and Stability | p. 59 |
Learning Objectives | p. 59 |
Introduction | p. 59 |
Rates and Order of Reaction | p. 59 |
Zero-Order Reactions | p. 60 |
First-Order Reactions | p. 61 |
Second-Order Kinetics | p. 63 |
Factors Affecting Reaction Kinetics | p. 65 |
Catalysis | p. 65 |
Effect of Temperature | p. 65 |
Effect of Solvent | p. 67 |
Effect of pH | p. 67 |
Presence of Additives | p. 67 |
Pathways and Prevention of Chemical Decomposition of Drugs | p. 68 |
Hydrolysis | p. 68 |
Control of Drug Hydrolysis | p. 69 |
Oxidation | p. 70 |
Control of Drug Oxidation | p. 72 |
Photolysis | p. 72 |
Control of Photodegradation of Drugs | p. 72 |
Review Questions | p. 73 |
Bibliography | p. 73 |
Interfacial Phenomena | p. 75 |
Learning Objectives | p. 75 |
Introduction | p. 75 |
Liquid Interfaces | p. 75 |
Surface and Interfacial Tensions | p. 75 |
Surface Free Energy | p. 75 |
Adsorption at Solid-Gas Interfaces | p. 77 |
Physical Adsorption | p. 77 |
Chemical Adsorption | p. 73 |
Adsorption Isotherms | p. 78 |
Freundlich Adsorption Isotherm | p. 78 |
Langmuir Adsorption Isotherm | p. 79 |
BET Adsorption Isotherm | p. 80 |
Type of Isotherms | p. 80 |
Adsorption at Solid-Liquid Interface | p. 81 |
Factors Affecting Adsorption from Solution | p. 81 |
Application of Adsorption | p. 82 |
Wettability and Wetting Agents | p. 83 |
Wetting Agents | p. 83 |
Protein Adsorption | p. 84 |
Review Questions | p. 84 |
Bibliography | p. 85 |
Rheology | p. 87 |
Learning Objectives | p. 87 |
Introduction | p. 87 |
Newtonian Flow | p. 87 |
Temperature Dependence and Viscosity of Liquids | p. 88 |
Non-Newtonian Flow | p. 88 |
Plastic Flow | p. 88 |
Pseudoplastic Flow | p. 90 |
Dilatant Flow | p. 90 |
Thixotropy | p. 91 |
Hysteresis Loop | p. 91 |
Negative Thixotropy | p. 93 |
Pharmaceutical Applications of Rheology | p. 93 |
Review Questions | p. 94 |
Bibliography | p. 94 |
Disperse System Basics | p. 95 |
Learning Objectives | p. 95 |
Introduction | p. 95 |
Types of Colloidal Systems | p. 96 |
Lyophilic Colloids | p. 96 |
Lyophobic Colloids | p. 96 |
Association Colloids | p. 97 |
Kinetic Properties of Colloids | p. 97 |
Brownian Movement | p. 97 |
Diffusion | p. 96 |
Sedimentation | p. 96 |
Electrical Properties | p. 99 |
Ionization | p. 99 |
Ion Adsorption | p. 100 |
Ion Dissolution | p. 100 |
Electrostatic Effect | p. 100 |
Electrical Double Layer | p. 100 |
Nerst and Zeta Potentials | p. 102 |
DLVO Theory | p. 102 |
Electrophoretic Phenomena | p. 102 |
Stability of Colloids | p. 103 |
Aggregation | p. 104 |
Coagulation | p. 104 |
Flocculation | p. 104 |
Review Questions | p. 104 |
Bibliography | p. 105 |
Surfactants and Micelles | p. 107 |
Learning Objectives | p. 107 |
Introduction | p. 107 |
Surfactants | p. 107 |
Types of Surfactants | p. 108 |
Anionic Surfactants | p. 108 |
Cationic Surfactants | p. 109 |
Nonionic Surfactants | p. 109 |
Ampholytic Surfactants | p. 109 |
HLB Systems | p. 110 |
Micelles | p. 111 |
Types of Micelles | p. 114 |
CMC and Micellar Size | p. 114 |
Micellar Solubilization | p. 115 |
Factors Affecting Solubilization | p. 115 |
Nature of Surfactants | p. 115 |
Nature of Solubilizates | p. 116 |
Effect of Temperature | p. 116 |
Effect of pH | p. 116 |
Pharmaceutical Applications of Micellar Solubilization | p. 116 |
Thermodynamics of Solubilization | p. 117 |
Krafft Point | p. 118 |
Cloud Point | p. 119 |
Review Questions | p. 119 |
Bibliography | p. 120 |
Pharmaceutical Suspensions | p. 123 |
Learning Objectives | p. 123 |
Introduction | p. 123 |
Classification of Suspensions | p. 123 |
Characteristics of Pharmaceutical Suspensions | p. 124 |
Formulation of Suspensions | p. 125 |
Flocculation and Deflocculation | p. 126 |
Properties of Deflocculated (Dispersed) Particles | p. 129 |
Properties of Flocculated Particles | p. 129 |
Suspension Stability | p. 130 |
Adhesion of Suspension Particles to Containers | p. 130 |
Sedimentation Parameters | p. 130 |
Sedimentation and Stoke's Law | p. 131 |
Review Questions | p. 132 |
Bibliography | p. 133 |
Pharmaceutical Emulsions | p. 135 |
Learning Objectives | p. 135 |
Introduction | p. 135 |
Advantages of Emulsion Dosage Forms | p. 135 |
Types of Emulsions | p. 135 |
Oil-in-Water Emulsions | p. 136 |
Water-in-Oil Emulsions | p. 136 |
Multiple Emulsions | p. 137 |
Microemulsions | p. 137 |
Roles of Interfacial Free Energy on Emulsification | p. 137 |
Formulations of Emulsions | p. 138 |
Emulsifying Agents | p. 138 |
Surfactants | p. 140 |
Hydrophilic Colloids | p. 140 |
Finely Divided Solid Particles | p. 141 |
Types of Instability in Emulsions | p. 141 |
Creaming and Sedimentation | p. 141 |
Breaking and Coalescence | p. 142 |
Phase Inversion | p. 143 |
Microbial Growth | p. 143 |
Review Questions | p. 143 |
Bibliography | p. 144 |
Pharmaceutical Solutions | p. 145 |
Learning Objectives | p. 145 |
Introduction | p. 145 |
pH and Solubility | p. 146 |
Buffer and Buffer Capacity | p. 146 |
Vehicles | p. 148 |
Types of Solutions | p. 148 |
Syrups | p. 148 |
Elixirs | p. 149 |
Tinctures | p. 149 |
Miscellaneous Solutions | p. 149 |
Dry or Lyophilized Mixtures for Solution | p. 150 |
Review Questions | p. 150 |
Bibliography | p. 150 |
Tablets | p. 153 |
Learning Objectives | p. 153 |
Introduction | p. 153 |
Types of Tablets | p. 153 |
Swallowable Tablets | p. 153 |
Effervescent Tablets | p. 154 |
Chewable Tablets | p. 154 |
Buccal and Sublingual Tablets | p. 154 |
Lozenges | p. 154 |
Coated Tablets | p. 154 |
Controlled-Release Tablets | p. 155 |
Immediate-Release Tablets | p. 156 |
Tablet Formulation | p. 156 |
Diluents | p. 156 |
Adsorbents | p. 157 |
Moistening Agents | p. 157 |
Binding Agents | p. 157 |
Glidants | p. 158 |
Lubricants | p. 158 |
Disintegrants | p. 158 |
Miscellaneous | p. 159 |
Powder Flow and Compressibility | p. 159 |
Manufacturing of Tablets | p. 159 |
Relationship among Disintegration, Dissolution, and Absorption | p. 160 |
Evaluation of Tablets | p. 161 |
Review Questions | p. 161 |
Bibliography | p. 163 |
Capsules | p. 165 |
Learning Objectives | p. 165 |
Introduction | p. 165 |
Hard Gelatin Capsules | p. 166 |
Advantages and Disadvantages of Hard Gelatin Capsules | p. 166 |
Formulation of Hard Gelatin Capsules | p. 167 |
Soft Gelatin Capsules | p. 168 |
Formulation of Soft Gelatin Capsules | p. 169 |
Evaluation of Capsules | p. 170 |
Review Questions | p. 171 |
Bibliography | p. 171 |
Injectable Dosage Forms | p. 173 |
Learning Objectives | p. 173 |
Introduction | p. 173 |
Isotonicity | p. 174 |
Parenteral Routes of Administration | p. 174 |
Intravenous Route | p. 174 |
Intramuscular Route | p. 175 |
Subcutaneous Route | p. 175 |
Other Routes | p. 175 |
Formulation of Parenteral Products | p. 176 |
Physicochemical Properties of the Drug | p. 176 |
Excipients in Parenteral Formulations | p. 176 |
Vehicles | p. 177 |
Sterilization of Parenteral Products | p. 177 |
Filtration | p. 177 |
Dry Heat Sterilization | p. 178 |
Steam Sterilization | p. 178 |
Radiation Sterilization | p. 178 |
Types of Parenteral Dosage Forms | p. 178 |
Solutions | p. 178 |
Suspensions | p. 179 |
Emulsions | p. 179 |
Dry Powders | p. 179 |
Evaluation of Injectable Products | p. 179 |
Sterility | p. 180 |
Pyrogens | p. 180 |
Particulate Matters | p. 180 |
Review Questions | p. 181 |
Bibliography | p. 181 |
Semisolid Dosage Forms | p. 183 |
Learning Objectives | p. 183 |
Introduction | p. 183 |
Ointments | p. 183 |
Types of Ointment Bases | p. 183 |
Hydrocarbon Bases | p. 184 |
Absorption Bases | p. 184 |
Emulsion Bases | p. 184 |
Water-Soluble Bases | p. 185 |
Incorporation of Drugs into Ointment | p. 185 |
Creams | p. 185 |
Gels | p. 186 |
Lotions | p. 187 |
Pastes | p. 187 |
Review Questions | p. 187 |
Bibliography | p. 188 |
Inserts, Implants, and Devices | p. 189 |
Learning Objectives | p. 189 |
Introduction | p. 189 |
Inserts | p. 189 |
Implants | p. 191 |
Suppositories | p. 192 |
Aerosol Products | p. 193 |
Nebulizers | p. 193 |
Metered-Dose Inhalers (MDIs) | p. 195 |
Powder Inhalers | p. 195 |
Transdermal Patches | p. 196 |
Review Questions | p. 197 |
Bibliography | p. 197 |
Pharmaceutical Polymers | p. 199 |
Learning Objectives | p. 199 |
Introduction | p. 199 |
Definitions and Architectures of Polymers | p. 199 |
Polymer Molecular Weight and Weight Distribution | p. 204 |
Biodegradablity and Biocompatibility | p. 205 |
Polymer Solubility | p. 205 |
Block Copolymers | p. 206 |
Intelligent or Stimuli-Sensitive Polymers | p. 207 |
Water-Soluble Polymers | p. 208 |
Bioadhesive/Mucoadhesive Polymers | p. 209 |
Review Questions | p. 209 |
Bibliography | p. 210 |
Drug Delivery Systems | p. 211 |
Learning Objectives | p. 211 |
Introduction | p. 211 |
Prodrugs | p. 212 |
Soluble Macromolecular Carriers | p. 213 |
Particulate Carrier Systems | p. 214 |
Liposomes | p. 215 |
Types of Liposomes | p. 215 |
Fabrication of Liposomes | p. 216 |
Microparticles and Nanoparticles | p. 218 |
Fabrication of Microparticulates | p. 219 |
Nanoparticles | p. 223 |
Oral Drug Delivery | p. 224 |
Alternative Routes of Delivery | p. 225 |
Buccal and Sublingual Drug Delivery | p. 225 |
Nasal Drug Delivery | p. 226 |
Pulmonary Drug Delivery | p. 227 |
Ocular Drug Delivery | p. 227 |
Rectal Drug Delivery | p. 228 |
Vaginal Drug Delivery | p. 228 |
Review Questions | p. 229 |
Bibliography | p. 229 |
Protein- and Peptide-Based Dosage Forms | p. 231 |
Learning Objectives | p. 231 |
Introduction | p. 231 |
Structure of Peptides and Proteins | p. 232 |
Primary Structure | p. 234 |
Secondary Structure | p. 235 |
Tertiary Structure | p. 235 |
Quaternary Structures | p. 235 |
Hydrophobicity of Peptides and Proteins | p. 235 |
Solubility of Peptides and Proteins | p. 236 |
Instability of Peptides and Proteins | p. 237 |
Physical Instability | p. 237 |
Denaturation | p. 237 |
Aggregation and Precipitation | p. 238 |
Surface Adsorption | p. 238 |
Chemical Instability | p. 238 |
Hydrolysis | p. 239 |
Deamidation | p. 239 |
Oxidation | p. 239 |
Racemization | p. 240 |
Disulfide Exchange | p. 240 |
Formulation of Proteins and Peptides | p. 240 |
Additives | p. 240 |
Lyophilized Proteins | p. 241 |
Chemical Modification | p. 242 |
PEGylation | p. 242 |
Antibody-Based Therapy and Delivery | p. 242 |
Antigenicity and Immunogenicity | p. 244 |
Review Questions | p. 244 |
Bibliography | p. 245 |
Biotechnology-Based Dosage Forms | p. 247 |
Learning Objectives | p. 247 |
Introduction | p. 247 |
Genes and Gene Expression | p. 247 |
Gene Silencing | p. 248 |
Classification of Gene-Silencing Technologies | p. 249 |
Antisense Oligonucleotides | p. 249 |
Triplex-Forming Oligonucleotides | p. 250 |
Peptide Nucleic Acids | p. 250 |
Antisense RNA | p. 250 |
Aptamers | p. 250 |
Ribozymes | p. 251 |
RNA Interference | p. 251 |
Gene Therapy | p. 251 |
Retroviral Vector | p. 252 |
Moloney Murine Leukemia Viruses | p. 253 |
Lentiviruses | p. 253 |
Adenoviral Vectors | p. 254 |
Adeno-Associated Virus Vectors | p. 254 |
Herpes Simplex Virus Vectors | p. 254 |
Gene Expression Plasmid | p. 254 |
Gene Delivery Systems | p. 255 |
Lipid-Based Gene Delivery | p. 256 |
Peptide-Based Gene Delivery | p. 257 |
Polymer-Based Gene Delivery | p. 258 |
Review Questions | p. 258 |
Bibliography | p. 259 |
Answers to Review Questions | p. 261 |
Drug Development and Regulatory Process | p. 261 |
Pharmaceutical and Formulation Considerations | p. 261 |
Biopharmaceutical and Physiological Considerations | p. 266 |
Complexation and Protein Binding | p. 267 |
Chemical Kinetics and Stability | p. 269 |
Interfacial Phenomenon | p. 270 |
Rheology | p. 271 |
Disperse System Basics | p. 272 |
Surfactants and Micelles | p. 275 |
Pharmaceutical Suspensions | p. 276 |
Pharmaceutical Emulsions | p. 277 |
Pharmaceutical Solutions | p. 279 |
Tablets | p. 279 |
Capsules | p. 280 |
Injectable Dosage Forms | p. 280 |
Semisolid Dosage Forms | p. 281 |
Inserts, Implants, and Devices | p. 281 |
Pharmaceutical Polymers | p. 281 |
Drug Delivery Systems | p. 282 |
Protein- and Peptide-Based Dosage Forms | p. 283 |
Biotechnology-Based Dosage Forms | p. 283 |
Index | p. 285 |
Table of Contents provided by Ingram. All Rights Reserved. |
An electronic version of this book is available through VitalSource.
This book is viewable on PC, Mac, iPhone, iPad, iPod Touch, and most smartphones.
By purchasing, you will be able to view this book online, as well as download it, for the chosen number of days.
Digital License
You are licensing a digital product for a set duration. Durations are set forth in the product description, with "Lifetime" typically meaning five (5) years of online access and permanent download to a supported device. All licenses are non-transferable.
More details can be found here.
A downloadable version of this book is available through the eCampus Reader or compatible Adobe readers.
Applications are available on iOS, Android, PC, Mac, and Windows Mobile platforms.
Please view the compatibility matrix prior to purchase.